Press Releases

igc pharma
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
Read More →
igc-ad1
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
Read More →
healthcare summit tgr-63 biotech igc pharma
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
Read More →
alzheimer igc pharma
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
Read More →
alzheimer igc pharma
Promising Results: TGR-63 Enhances Memory in Alzheimer’s Mouse Model
Read More →
igc pharma
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a Buy Recommendation and $3.00 Price Target
Read More →
igc pharma
IGC Pharma Reports Third Quarter Fiscal 2024 Results
Read More →
alzheimer igc pharma
IGC Pharma Announces TGR-63 Reduces Anxiety in Alzheimer’s Mouse Model
Read More →
healthcare summit tgr-63 biotech igc pharma
IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s
Read More →
clincloud
IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial
Read More →
igc-ad1 igc pharma
Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s
Read More →
healthcare summit tgr-63 biotech igc pharma
IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024
Read More →
artificial intelligence igc pharma
IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials
Read More →
healthcare summit tgr-63 biotech igc pharma
IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives
Read More →
igc pharma
IGC Pharma Reports Second Quarter Fiscal 2024 Results
Read More →
healthcare summit tgr-63 biotech igc pharma
IGC Pharma Granted European Patent for Groundbreaking Cannabinoid-Based Pain Topical Relief Therapy
Read More →